SCHEMBL24298137

SCHEMBL24298137

Cc1cccc(C)c1-c1cc(Oc2cccc(N)c2)nc(NSc2cccc(N)c2)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR39 O43194 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ F10 P00742 1/20 0.32
▸ MAPT P10636 3/20 0.32
▸ POLB P06746 1/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ ROCK1 Q13464 1/20 0.31
▸ NUDT1 P36639 2/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ ATM Q13315 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ BRCA1 P38398 1/20 0.31
▸ HBB P68871 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310009 0.86 GPR39 (0.45) GPR39ALDH1A1MAPTCYP1A2CYP2C9
SCHEMBL24330885 0.84 TDP1 (0.34) MAPTPOLBKDM4ENPC1RAB9A
SCHEMBL24330653 0.84 FFAR1 (0.38) CYP1A2
SCHEMBL24309507 0.84 CYP1A2 (0.35) GPR39F10MAPTCYP1A2CYP2C9
SCHEMBL24330884 0.81 F10 (0.40) GPR39F10
SCHEMBL24310447 0.78 USP1 (0.33) GPR39ALDH1A1
SCHEMBL29457761 0.77 SMN1; SMN2 (0.45) ALDH1A1CYP3A4MAPTPOLB
SCHEMBL24298133 0.77 SMN1; SMN2 (0.45) ALDH1A1CYP3A4MAPTPOLB
SCHEMBL24310347 0.76 GPR39 (0.39) GPR39ALDH1A1MAPTCYP1A2CYP2C9
SCHEMBL24310766 0.73 GPR39 (0.44) GPR39ALDH1A1MAPTCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076621-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback